Heart rhythm procedure with left atrial appendage closure
Part of Heart & circulation clinical trials.
This trial tests a procedure that closes off a small pouch in the heart (left atrial appendage) while also treating irregular heartbeat (atrial fibrillation) with a catheter ablation procedure. The goal is to reduce your stroke risk and treat your symptoms without needing blood thinners long-term.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have documented atrial fibrillation (irregular heartbeat) that is either paroxysmal (comes and goes) or persistent (lasts more than a week)
- Your doctor recommends catheter ablation (a procedure to fix the irregular heartbeat)
- You are at least 18 years old and willing to sign consent forms
- You can tolerate blood-thinning medications for 60 days after the procedure, then switch to aspirin
- Your heart pumps at least 30% of blood with each beat (ejection fraction >30%)
- You do not have severe kidney disease, lung disease, or certain heart valve problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new method to treat persistent atrial fibrillation (a long-lasting irregular heartbeat) to see if it helps patients who haven't been helped by medication. It focuses on cleaning up the back wall of the heart to restore a normal rhythm.
This trial tests a more precise way to burn (ablate) the back wall of the left upper heart chamber during the first ablation for persistent atrial fibrillation (AF). It aims to improve heart rhythm control and reduce the chance of AF coming back.
This trial tests a two-step procedure for persistent atrial fibrillation that combines a heart ablation with isolation of a small heart pouch. It aims to see if this approach is more effective than standard care.
This study tests a new approach for people with atrial fibrillation (a type of irregular heartbeat) who are also at high risk for stroke. It combines a procedure to fix the heart's electrical signals with closing off a small pouch in the heart to reduce stroke risk, potentially avoiding long-term blood thinners.
This trial tests a newer, possibly safer way to treat persistent atrial fibrillation using pulsed field ablation. It compares standard vein isolation alone to adding extra ablation spots to improve success.
This trial tests a catheter ablation procedure for people with persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days but less than a year). It aims to see if the procedure is safe and effective for restoring a normal heart rhythm.
Hear when a new Paroxysmal AF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.